CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: May 27, 2013
Result type: Reports
Project Number: SR0332-000
Product Line: Reimbursement Review

Generic Name: Somatropin

Brand Name: Genotropin

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: Growth hormone deficiency, adult

Indications: Growth hormone deficiency, adult

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 20, 2013

Recommendation Type: List with criteria/condition